John Nkengasong, director of the Africa Centres for Disease Control and Prevention, claims that new COVID-19 cases have increased by 26% on the African continent.
According to Nkengasong, the continent recorded 94,145 new COVID-19 cases in week 22 (31 May – 6 June 2021), a 26 percent increase.
During a press conference on Thursday, the Africa CDC director stated that the continent’s 4,969,847 COVID-19 cases account for 2.9 percent of all cases reported globally. He also mentioned that the number of new cases reported in Africa has increased by 13% on average each week.
He revealed that in the week under review, 1,977 new deaths were reported in Africa, up from 1,934 the previous week, representing a two percent increase in new deaths.
Over 133,000 deaths have been reported in Africa, according to the Africa CDC director, with 4,477,813 recoveries. According to him, the southern region has the highest proportion of new cases (51 percent ). The northern region (26%) is followed by the eastern region (14%), the central region (7%), and the western region (7%). (three percent ).
“To date, over 49 million COVID-19 tests (49,083,332), have been conducted in African Union Member States since the pandemic started. The overall positivity rate is 10.1 percent and the test-per-case ratio is 9.9”, he said.
The virologist went on to say that 13 African countries, including Nigeria, are now reporting the Delta (B.1.617.2) variant, which was first discovered in India.
Nkengasong stated that the Mastercard Foundation and the Africa CDC had announced the launch of the Saving Lives and Livelihoods Initiative earlier this week. According to him, the initiative aims to increase access to safe and effective vaccines across Africa, saving lives and accelerating the continent’s economic recovery.
Specifically, the Saving Lives and Livelihoods Initiative will acquire vaccines for at least 50 million people and enable the delivery of safe and efficacious vaccinations to millions more across the continent.
The initiative will strengthen the continent’s capacity to manufacture vaccines through a focus on human capital development, enabling work opportunities for young people.
Under this initiative, the Mastercard Foundation will deploy USD 1.3 billion over the next three years under this initiative. This partnership will also lay the groundwork for vaccine manufacturing in Africa through a focus on human capital development, he explained.